MDJM Faces Nasdaq Delisting After Panel Rejects Reinstatement Bid

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks MDJM ( (UOKAF) ) has provided an announcement. MDJM Ltd disclosed that, following a period during which its shares closed at or below $0.10 for 10 consecutive trading days, Nasdaq staff notified the company on March 13, 2026, that its securities would be suspended from trading effective March 20, 2026. The company requested a hearing on March 20, 2026, but on May 14, 2026, an independent Nasdaq Hearings Panel denied reinstatement and decided to delist MDJM’s Class A ordinary shares, signaling a significant setback for the company’s access to U.S. capital markets and potentially affecting liquidity for existing shareholders. MDJM formally reported the Panel’s May 14, 2026 decision in a Form 6-K dated May 19, 2026, and noted that this filing is incorporated by reference into its existing shelf and employee benefit registration statements, ensuring that U.S. regulatory disclosures remain current despite the impending delisting. The removal of its Nasdaq listing may force the company to seek alternative trading venues or funding options and could alter its visibility and valuation within the international investment community. More about MDJM MDJM Ltd is a foreign private issuer listed in the United States that has traded its Class A ordinary shares on Nasdaq, focusing on accessing global capital markets for its growth and financing needs. The company operates within the broader financial and capital markets ecosystem, relying on public equity listings to support its corporate strategy and investor base. Average Trading Volume: 566,943 Technical Sentiment Signal: Sell Current Market Cap: $374.1K